Imidazoquinolines as lipid kinase inhibitors

Details for Australian Patent Application No. 2006249071 (hide)

Owner Novartis AG

Inventors Furet, Pascal; Garcia-Echeverria, Carlos; Stauffer, Frederic

Agent Davies Collison Cave

Pub. Number AU-B-2006249071

PCT Pub. Number WO2006/122806

Priority 0510390.8 20.05.05 GB

Filing date 18 May 2006

Wipo publication date 23 November 2006

Acceptance publication date 1 April 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4188 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/122806 Priority application(s): WO2006/122806

1 April 2010 Application Accepted

  Published as AU-B-2006249071

29 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249072-Ball-shaped coupling comprising a sealed contact area

2006249065-Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics